Brief: Mediland Pharm Says Qtrly Total Revenue A$11.7 Mln
Jan 30 (Reuters) - Mediland Pharm Ltd MPH.AX :
* QTRLY TOTAL REVENUE A$11.7 MILLION
* BUSHFIRES IN AUSTRALIA & CORONAVIRUS OUTBREAK IN CHINA
LIKELY TO
ADVERSELY IMPACT CO'S REVENUES IN UPCOMING QUARTER
* INTENDS TO SIGNIFICANTLY EXPAND ITS E-COMMERCE OPERATION
WITH
SALES TO CHINA-BASED CONSUMERS
* FAST-TRACKING DEVELOPMENT OF NEW IMMUNE HEALTH PRODUCT
Source text for Eikon: ID:nASX4wJpsq
Further company coverage: MPH.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Innlanz
See all newsBrief: Innlanz Says Revenues For Current Quarter Will Likely Be Higher
Australia Stock Exchange release from INNLANZ : Half Year Accounts
Australia Stock Exchange release from INNLANZ : PRE_NR Ends: 08:13:17
Australia Stock Exchange release from INNLANZ : Change of Auditor
Australia Stock Exchange release from INNLANZ : PRE_NR Ends: 08:22:07